From OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders
November 4, 2019OHC is leading the way in the fight against breast cancer by assessing every new OHC breast cancer patient against national guidelines that will determine if they should seek genetic testing for mutations.
It’s important for patients to know this information because it can help them and the care team make decisions such as surgical options, medical treatments, preventative interventions, screenings, and counseling for their family members.
“When we have a newly diagnosed breast cancer patient, we assess the patient against criteria established by the National Comprehensive Cancer Network (NCCN). If the patient meets the criteria, they are referred to our OHC cancer genetic specialists for further counseling and testing,” said Andy Guinigundo, MSN, APRN, advanced practice provider at OHC.
This year to date, OHC has assessed 100% of all newly diagnosed breast cancer patients, and of those, 146 met NCCN criteria. Of the 146, 65% had appointments for genetic services, which is well above the national average of 33%. (The remaining 35% opted not to pursue genetic services.)
Armed with this knowledge, patients and their OHC doctors discuss options for their cancer. It’s another way OHC is ensuring breast cancer patients receive the best treatment plan to fight their cancer.
It also provides valuable information to family members who may be at risk and not know it.
“For all patients who test positive, immediate family members are offered genetic testing within 90 days,” said Andy.
“When someone is diagnosed with breast cancer, we want them to feel hopeful about their future. One of the best ways we do that is to offer patients the best possible treatment options. The NCCN screenings are one more way we are making that possible. We’re giving patients the best chance at beating their cancer,” he added.Comments (0)